Pfizer Animal Health just announced an FDA-approved mastitis treatment. This treatment “provides dairy producers with a wider range of management options than any other dry cow mastitis treatment on the market.”
It’s SPECTRAMAST DC and it fights major environmental pathogens and Staphylococcus aureus, has a zero-day milk discard period following a 30-day dry period, and offers the shortest meat withdrawal available. Most of the current mastitis treatments were developed more than 20 years ago, and Pfizer recognized the importance for continued research and development of a broader spectrum product. “Traditionally, mastitis treatments for dry cows were not labeled for environmental pathogens,” said Bruce Beachnau, DVM, dairy veterinary operations, Pfizer Animal Health. “SPECTRAMAST DC was proven effective for Staphylococcus aureus, and environmental pathogens such as Streptococcus dysgalactiae, and Streptococcus uberis.”
I am seriously glad I don’t have to record a radio commercial about this. It’s a whole lot easier to type some of those words than to say them!